Re: Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome Reply

被引：0
|
作者：
Lainas, T. G. [1 ]
Kolibianakis, E. M. [2 ]
机构：
[1] Eugonia Unit Assisted Reprod, Athens, Greece
[2] Aristotle Univ Thessaloniki, Human Reprod Unit, Dept Obstet & Gynecol 1, Papageorgiou Gen Hosp,Med Sch, GR-54006 Thessaloniki, Greece
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2015年 / 122卷 / 04期
关键词：
D O I：
10.1111/1471-0528.13068
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：585 / 586
页数：2
相关论文
共 50 条
  • [1] Serum vascular endothelial growth factor levels following luteal gonadotrophin-releasing hormone antagonist administration in women with severe early ovarian hyperstimulation syndrome
    Lainas, G. T.
    Kolibianakis, E. M.
    Sfontouris, I. A.
    Zorzovilis, I. Z.
    Petsas, G. K.
    Lainas, T. G.
    Tarlatzis, B. C.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 (07) : 848 - 855
  • [2] Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?
    Casper, RF
    HUMAN REPRODUCTION, 1996, 11 (06) : 1144 - 1146
  • [3] Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration
    Ludwig, M
    Jelkmann, W
    Bauer, O
    Diedrich, K
    HUMAN REPRODUCTION, 1999, 14 (10) : 2437 - 2441
  • [4] Vascular endothelial growth factor response to exogenous chorionic gonadotropic hormone in the luteal phase of women with a history of severe ovarian hyperstimulation syndrome
    Griesinger G.
    Dafopoulos K.
    Schultze-Mosgau A.
    Jelkmann W.
    Von Otte S.
    Diesing D.
    Diedrich K.
    Archives of Gynecology and Obstetrics, 2006, 274 (1) : 29 - 33
  • [5] Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation and use of a gonadotrophin releasing hormone antagonist
    Vani, S.
    Macdonald, S.
    Williams, A. R. W.
    Mason, J. I.
    Thong, K. J.
    Critchley, H. O. D.
    HUMAN REPRODUCTION, 2007, 22 : I44 - I45
  • [6] Effect of gonadotrophin-releasing hormone (GnRH) antagonist during the LH surge in normal women and during controlled ovarian hyperstimulation
    Christin-Maitre, S
    Olivennes, F
    Dubourdieu, S
    Chabbert-Buffet, N
    Charbonnel, B
    Frydman, R
    Bouchard, P
    CLINICAL ENDOCRINOLOGY, 2000, 52 (06) : 721 - 726
  • [7] Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist
    Vani, Susheel
    McDonald, Sarah E.
    Williams, Alistair R. W.
    Mason, J. Ian
    Thong, K. Joo
    Critchley, Hilary O. D.
    HUMAN REPRODUCTION, 2007, 22 (11) : 2981 - 2991
  • [8] Vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome
    Jellad, S.
    Soyah, N.
    Basly, M.
    Chibani, M.
    Rachdi, R.
    HUMAN REPRODUCTION, 2019, 34 : 458 - 459
  • [9] Vascular endothelial growth factor antagonist reduces the early onset and the severity of ovarian hyperstimulation syndrome
    Jellad, S.
    Hassine, A. Haj
    Basly, M.
    Mrabet, A.
    Chibani, M.
    Rachdi, R.
    JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2017, 46 (01): : 87 - 91
  • [10] Effect of gonadotrophin-releasing hormone agonist treatment on growth hormone secretion in women with polycystic ovarian syndrome
    Kaltsas, T
    Pontikides, N
    Krassas, GE
    Seferiadis, K
    Lolis, D
    Messinis, IE
    HUMAN REPRODUCTION, 1998, 13 (01) : 22 - 26
12345